의료용 마리화나 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00022901
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 181
Buy Now

의료용 마리화나 시장은 2021년에 117억 650만 달러였으며 2028년에는 400억 2759만 달러에 이를 것으로 예상됩니다. 2022년부터 2028년까지 CAGR 19.2%로 성장할 것으로 추정됩니다.



의료용 대마초로도 알려진 의료용 마리화나는 치료 분야에서의 적용이 증가함에 따라 날이 갈수록 인기를 얻고 있습니다. 만성 질환 치료 및 통증 관리에 사용할 수 있는 대마초 사티바 식물에서 파생됩니다.



의료용 마리화나 시장은 제품, 응용 프로그램, 유통 채널 및 지역으로 분류됩니다. 지리적으로 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 광범위하게 분류됩니다. 이 보고서는 시장 동향 및 역학과 같은 매개 변수에 중점을 둔 시장에 대한 통찰력과 심층 분석 및 세계적으로 선도적인 시장 참여자의 경쟁 분석을 제공합니다.



전략적 통찰력



의료용 마리화나 시장의 수익성 있는 지역



시장 통찰력



의료용 마리화나 제품 승인 증가



마리화나의 의학적 잠재력은 다양한 연구자들과 회사들이 마리화나를 의료용으로 사용하도록 끌어들였습니다. 예를 들어, 테트라히드로칸나비놀(THC)은 의약품 생산에 주로 사용됩니다. 미국 식품의약국(FDA)은 THC와 유사한 구조를 가진 합성 유래 제품인 나볼린을 활성 성분으로 함유한 Cesamet과 같은 THC 기반 의약품을 승인했습니다. Cesamet은 화학 요법을 받는 환자의 메스꺼움 치료를 위해 처방됩니다. Cesamet은 일반적으로 다른 약물이 메스꺼움과 구토를 조절할 수 없을 때 처방됩니다. FDA는 또한 마리놀과 신드로스를 미국에서 치료용으로 승인했습니다. 마리놀과 신드로스는 대마초의 향정신성 성분으로 간주되는 합성 9-THC인 활성 성분 드로나비놀을 함유하고 있습니다. 마리놀과 신드로스는 AIDS의 징후 중 하나로 발전된 소모성 증후군 환자의 식욕을 자극하기 위해 처방된다. 마찬가지로 다양한 마리화나 기반 제품이 승인되었거나 임상 시험 중입니다. 예를 들어, nabiximols(Sativex)는 캐나다에서 상용화된 승인된 약물입니다. Nabiximols는 다발성 경화증과 관련된 경련 및 신경병성 통증을 치료하는 데 사용되는 대마초 추출물입니다. THC와 기타 칸나비디올(CBD)의 조합으로 제조되었습니다. 2020년 2월 캐나다 회사인 CanaQuest Medical Corp은 캐나다 보건부에 멘타비놀의 생산 및 상업화 승인을 신청했습니다. Mentabinol은 THC 기반 제품으로 Cannabis Act에 따라 승인 신청이 접수되었습니다. 위에서 언급한 마리화나 기반 제품의 FDA 승인 증가는 의료용 마리화나 시장의 성장을 주도하고 있습니다.



제품 기반 통찰력



제품을 기준으로 의료용 마리화나 시장은 건조 형태와 추출물 형태로 양분됩니다. 추출물 양식 세그먼트는 2021년에 더 큰 시장 점유율을 차지했습니다. 또한 동일한 세그먼트는 예측 기간 동안 19.3%의 더 높은 CAGR을 기록할 것으로 예상됩니다. 추출물 형태 부문의 성장은 의료 분야에서 액체 추출물에 대한 수요 증가, 자연 건강 제품 소비로 인한 건강 및 웰빙 트렌드 증가, 말린 마리화나에 대한 추출물의 이점에 대한 인식 증가에 기인할 수 있습니다.



의료용 마리화나 시장, 제품별 - 2021년 및 2028년



응용 기반 통찰력



응용 프로그램에 따라 의료용 마리화나 시장은 통증 관리, 뚜렛 증후군, 알츠하이머병으로 분류됩니다. , 편두통, 우울증 및 불안, 다발성 경화증, 암 등. 통증 관리 부문은 2021년에 가장 큰 시장 점유율을 차지했습니다. 그러나 다발성 경화증 부문은 2022년부터 2028년까지 가장 빠른 CAGR 20.3%를 기록할 것으로 예상됩니다. 통증 관리 부문은 외상이나 고혈압의 유병률 증가로 인해 수요가 증가하고 있습니다. 근육 및 신경 자극제, 비만 및 당뇨병과 같은 생활 습관 장애의 유병률 증가.



유통 채널 기반 통찰력



유통 채널을 기준으로 의료용 마리화나 시장은 소매 약국, 전자 상거래 및 기타. 소매 약국 부문은 2021년에 가장 큰 시장 점유율을 차지했습니다. 그러나 전자 상거래 부문은 2022-2028년 동안 19.8%의 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 소매 약국 부문의 주요 추진 요인은 엄격하게 규제되는 공급망, 전문가 컨설팅 및 순응도를 개선하는 환자 솔루션입니다.



제품 출시 및 승인과 같은 유기적 개발은 의료용 마리화나 시장. 최근 주요 시장 개발 중 일부는 다음과 같습니다.



2021년 2월 CANAQUEST MEDICAL CORP는 PurCann Pharma(“PurCann“) 및 SiliCycle Inc.(“SiliCycle“)와 새로운 생산 및 유통 계약을 발표했습니다. ;). 이 계약은 CanaQuest가 전액 출자한 자회사인 ADC BioMedical Corp.을 통해 CanaQuest의 계획된 생산, 유통 및 멘타닌 및 멘타비놀 제형의 글로벌 수출을 용이하게 합니다.



회사 프로필



  • Aphria, Inc .

  • Canopy Growth Corporation

  • CanaQuest Medical Corporation

  • GW Pharmaceuticals

  • Organigram Holdings Inc.

  • VIVO Cannabis Inc

  • Panaxia Pharmaceutical Industries Ltd.

  • Phoena Holdings Inc.

  • Emerald Health Therapeutics Inc.

  • MARICANN INC.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the Medical Marijuana market?

Medical marijuana is a term for derivatives of the Cannabis sativa plant that are used to ease symptoms caused by certain medical conditions. Medical marijuana is also known as medical cannabis. Cannabis sativa contains many active compounds. The best known are delta-9 tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is the primary ingredient in marijuana. Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions. It's basically the same product as recreational marijuana, but it's taken for medical purposes.

Who are the major players in the medical marijuana market?

The medical marijuana market majorly consists of the players such as Aphria, Inc.; Canopy Growth Corporation; CanaQuest Medical Corporation; GW Pharmaceuticals; Organigram Holdings Inc.; VIVO Cannabis Inc.; Panaxia Pharmaceutical Industries Ltd.; Phoena Holdings Inc.; Emerald Health Therapeutics Inc.; and MARICANN INC.

What are the driving factors for the medical marijuana market across the country?

The factors that are driving and restraining factors that will affect the medical marijuana market in the coming years. Factors such as increasing approvals of medical marijuana products and rising acceptance of medicinal use of marijuana in America. However, the illegal use of cannabis as a street drug and misconceptions regarding marijuana is likely to have a negative impact on the growth of the market in the coming years.

Which segment is dominating the medical marijuana market?

The global medical marijuana market based on product is dried form and extract form. The extract form segment is likely to hold the largest share of the market in 2022. Moreover, the segment is anticipated to register the highest CAGR in the market during the forecast period.

The List of Companies - Medical Marijuana Market

  1. Aphria, Inc.
  2. Canopy Growth Corporation
  3. CanaQuest Medical Corporation
  4. GW Pharmaceuticals
  5. Organigram Holdings Inc.
  6. VIVO Cannabis Inc
  7. Panaxia Pharmaceutical Industries Ltd.
  8. Phoena Holdings Inc.
  9. Emerald Health Therapeutics Inc.
  10. MARICANN INC.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports